MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.

Up to half of patients with Graves' hyperthyroidism have signs of thyroid associated ophthalmopathy, but the factors that cause this disorder are unknown. We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic...

詳細記述

書誌詳細
主要な著者: Allahabadia, A, Heward, J, Nithiyananthan, R, Gibson, S, Reuser, T, Dodson, P, Franklyn, J, Gough, S
フォーマット: Journal article
言語:English
出版事項: 2001
その他の書誌記述
要約:Up to half of patients with Graves' hyperthyroidism have signs of thyroid associated ophthalmopathy, but the factors that cause this disorder are unknown. We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene. Allelic frequencies of these genes in patients with Graves' disease who did and did not have concurrent thyroid-associated ophthalmopathy did not differ, and are, therefore, unlikely to contribute to its development.

類似資料